Literature DB >> 2545497

Cell-free heterologous desensitization of adenylyl cyclase in S49 lymphoma cell membranes mediated by cAMP-dependent protein kinase.

M W Kunkel1, J Friedman, S Shenolikar, R B Clark.   

Abstract

We have examined the cell-free heterologous desensitization of adenylyl cyclase in plasma membrane preparations from S49 wild-type (WT) and kin- cells (which lack cAMP-dependent protein kinase) incubated with purified catalytic subunit of cAMP-dependent protein kinase (cA.PKc). cA.PKc caused a rapid (t1/2 = 40 s) decrease in the hormone responsiveness of adenylyl cyclase in the WT membrane preparations that mimicked the intact cell heterologous desensitization; that is, there was an increase in the Kact for both epinephrine and prostaglandin E1 (PGE1) stimulations of adenylyl cyclase induced at the receptor level because neither forskolin- nor NaF-stimulated activity was affected. The desensitization was independent of agonist occupancy of the receptor, and the effects were blocked both by the active fragment (amino acids 5-22) of the specific inhibitor of cA.PK and by p[NH]ppA. cA.PKc treatment of kin- membranes resulted in a heterologous desensitization that resembled the effects of WT adenylyl cyclase, with the exception that forskolin-stimulated activity was also reproducibly decreased by 24%. cA.PKc had no effect on WT membranes isolated from cells that had previously undergone maximal heterologous desensitization during treatment with 10 microM forskolin. In contrast, cA.PKc-induced heterologous desensitization of kin- membranes was additive with the epinephrine-induced homologous desensitization of intact cells. Cell-free desensitizations were reversed by incubation of membranes with cA.PKc and ADP, conditions that drive the kinase reaction backward. The similarities of our cell-free cA.PKc-mediated heterologous desensitization of adenylyl cyclase with the intact cell desensitization support our hypothesis that heterologous desensitization of the WT lymphoma cells is mediated by cA.PK via a mechanism independent of homologous desensitization.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2545497     DOI: 10.1096/fasebj.3.9.2545497

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  3 in total

1.  Biochemical and Cellular Specificity of Peptide Inhibitors of G Protein-Coupled Receptor Kinases.

Authors:  Faiza Baameur; Richard A Hammitt; Jacqueline Friedman; John S McMurray; Richard B Clark
Journal:  Int J Pept Res Ther       Date:  2014-03       Impact factor: 1.931

2.  Critical cysteines in the functional interaction of adenylyl cyclase isoform 6 with Gαs.

Authors:  Anjali Y Bhagirath; Vikram Bhatia; Manoj Reddy Medapati; Nisha Singh; Martha Hinton; Prashen Chelikani; Shyamala Dakshinamurti
Journal:  FASEB Bioadv       Date:  2021-11-22

3.  Rolipram, a type IV-specific phosphodiesterase inhibitor, facilitates the establishment of long-lasting long-term potentiation and improves memory.

Authors:  M Barad; R Bourtchouladze; D G Winder; H Golan; E Kandel
Journal:  Proc Natl Acad Sci U S A       Date:  1998-12-08       Impact factor: 11.205

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.